Furthermore, the HMT MMSET protein is upregulated in all cases of MM with t(4;14) (p16;q32) translocations, accounting for approximately 15–20% of all patients with a poor prognosis [61, 62]. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.